Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Assets (2016 - 2025)

Historic Return on Assets for Catalyst Pharmaceuticals (CPRX) over the last 16 years, with Q3 2025 value amounting to 0.21%.

  • Catalyst Pharmaceuticals' Return on Assets rose 400.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.25% for FY2024, which is 1100.0% up from last year.
  • Catalyst Pharmaceuticals' Return on Assets amounted to 0.21% in Q3 2025, which was up 400.0% from 0.22% recorded in Q2 2025.
  • Catalyst Pharmaceuticals' Return on Assets' 5-year high stood at 0.37% during Q1 2021, with a 5-year trough of 0.08% in Q2 2024.
  • Over the past 5 years, Catalyst Pharmaceuticals' median Return on Assets value was 0.21% (recorded in 2022), while the average stood at 0.21%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -2700bps in 2021, then surged by 1400bps in 2025.
  • Quarter analysis of 5 years shows Catalyst Pharmaceuticals' Return on Assets stood at 0.17% in 2021, then soared by 37bps to 0.23% in 2022, then tumbled by -43bps to 0.13% in 2023, then skyrocketed by 49bps to 0.2% in 2024, then grew by 7bps to 0.21% in 2025.
  • Its Return on Assets was 0.21% in Q3 2025, compared to 0.22% in Q2 2025 and 0.22% in Q1 2025.